Dermata Raises $4.1M, Unveils Tome Skincare Brand Ahead of Mid-2026 DTC Launch
Dermata Therapeutics pivoted to direct-to-consumer skincare, launching the Tome brand and planning its first product, a once-weekly Foundational Treatment, in mid-2026. The company raised $4.125 million in December 2025 and has $15.4 million in total proceeds to fund operations into early 2027.
1. Strategic Pivot to Direct-to-Consumer Skincare
Dermata shifted from prescription dermatology to direct-to-consumer skincare in September 2025, launching the Tome brand in March 2026 to target both consumers and in-office aestheticians with simplified, clinically informed products.
2. Upcoming Product Launches
The company is finalizing packaging and plans to launch its once-weekly Foundational Treatment skin renewal mask in mid-2026, followed shortly by an OTC Clearing Treatment targeting common acne.
3. Recent Financings and Cash Runway
Dermata raised $4.125 million in a December 2025 private placement and secured $15.4 million in total funding during 2025 and early 2026, providing capital to operate into the first quarter of 2027.
4. Leadership and Marketing Strategy
New Vice President of Marketing Kyra Peckaitis joined in March 2026 to spearhead branding and go-to-market efforts for the Tome line, with commercial packaging for the Foundational Treatment nearing completion.